Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Digital Trade Alignment: What May Be in Play in the Canada-U.S. Trade Deal 
TMU Picks Damage Control Over Fixing the Damage: Behind Its Shameful Response to the Devastating Benotto Report on Campus Antisemitism 
Thanks For Joining the Movement: French Constitutional Council Strikes Down Kids’ Social Media Ban 
Denial, Hate, and Silence: The Three Responses to Overwhelming Evidence of Canada’s Campus Antisemitism Crisis 
The Law Bytes Podcast, Episode 278: Ben Waldman on Gander Social and the Challenges of Building a Sovereign Social Network
